Abstract
Anticancer immunotherapies are highly desired. Conversely, unwanted inflammatory or immune responses contribute to oncogenesis, tumor progression, and cancer-related death. For non-immunogenic therapies to inhibit tumor growth, they must promote, not prevent, the activation of anticancer immune responses. Here, the central immunoregulatory role of brain-specific stromal cells and neurons as well as their ability to maintain an immunological balance and prevent the development of glioblastoma is discussed.
Originalsprog | Engelsk |
---|---|
Tidsskrift | OncoImmunology |
Vol/bind | 2 |
Udgave nummer | 12 |
Sider (fra-til) | e27091 |
ISSN | 2162-4011 |
DOI | |
Status | Udgivet - 1 dec. 2013 |